<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM867102"><item key="COMPOUND">SCF and CCL28</item></item></item><item><item key="GSM867102"><item key="COMPOUND">SCF and CCL28</item></item></item><item><item key="GSM867102"><item key="COMPOUND">SCF and CCL28</item></item></item><item><item key="GSM867099"><item key="COMPOUND">SCF</item></item></item><item><item key="GSM867099"><item key="COMPOUND">SCF</item></item></item><item><item key="GSM867099"><item key="COMPOUND">SCF</item></item></item></item><item key="id">2611</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">We identified chemokine (C-C motif) ligand 28 (CCL28) as a novel growth factor for HSPCs with the ability to enhance the proliferation...</item><item key="geo_gse_id">E-GEOD-35374</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>chemokine</item><item>serum</item><item>stem cell</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">gene-expression-analysis-of-ccl28-signaling-in-ish</item><item key="geo_id_plat">E-GEOD-35374_A-AFFY-44</item><item key="name">Gene expression analysis of CCL28 signaling in ishematopoietic stem and progenitor cells (HSPC) in culture</item><item key="created">Jul.12, 2014</item><item key="summary">We identified chemokine (C-C motif) ligand 28 (CCL28) as a novel growth factor for HSPCs with the ability to enhance the proliferation potential of fetal, neonatal and adult CD34+ HSPCs after one week of culture in serum-free medium containing limiting stem cell factor (SCF) concentrations. Importantly, CCL28 could increase the progenitor potential of CB- and bone marrow (BM) derived CD34+ cells as measured by colony assays. Furthermore, treatment of CB CD34hiCD38loCD90+CD45RA- cells with CCL28 significantly enhanced the ability of the cells to long-term repopulate immunodeficient mice compared to SCF-treated cultures. Our findings show that CCL28 is a potent growth factor for human HSCs and suggest that it should be further exploited in clinical strategies for ex vivo expansion. Human CD34+CD38-CD45RAlowCD90+ cord blood cells were cultured in vitro for 18 hrs with CCL28 and SCF or SCF alone.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35374</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-35374/samples/</item></data></biogps>
